select a format

Single User License
USD 1500 INR 97485
Site License
USD 3000 INR 194970
Corporate User License
USD 4500 INR 292455

Alternatively

Request a quote
Request a Customized research
Request for Sample Report

NEWSLETTER BY CATEGORY




Recent Viewed Reports


Why Ken Reasearch?


Testimonials

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements.... "Senior Associate, Booz Allen Hamilton"

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ... "Mohit Mittal, Consultant, KPMG Advisory Services"

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies.... "Mustafa Masood, Financial Analyst , Coldwell Banker Riyadh"

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"


Kuhnil Pharmaceutical Co., Ltd.-Product Pipeline Review-2016

Kuhnil Pharmaceutical Co., Ltd.-Product Pipeline Review-2016


  • Products Id :- GMDHC08067CDB
  • |
  • Pages: 39
  • |
  • June 2016
  • |
  • |
  Request for Sample Report

Executive Summary

Kuhnil Pharmaceutical Co., Ltd.-Product Pipeline Review-2016

Summary

Global Markets Direct's, 'Kuhnil Pharmaceutical Co., Ltd.-Product Pipeline Review-2016', provides an overview of the Kuhnil Pharmaceutical Co., Ltd.'s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Kuhnil Pharmaceutical Co., Ltd., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

The report provides a snapshot of the pipeline therapeutic landscape of Kuhnil Pharmaceutical Co., Ltd.

The report provides overview of Kuhnil Pharmaceutical Co., Ltd. including its business description, key facts, and locations and subsidiaries

The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities

The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages

The report assesses Kuhnil Pharmaceutical Co., Ltd.'s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type

The report features Kuhnil Pharmaceutical Co., Ltd.'s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons To Buy

Evaluate Kuhnil Pharmaceutical Co., Ltd.'s strategic position with total access to detailed information on its product pipeline

Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Identify and understand important and diverse types of therapeutics under development for Kuhnil Pharmaceutical Co., Ltd.

Identify potential new clients or partners in the target demographic

Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics

Devise corrective measures for pipeline projects by understanding Kuhnil Pharmaceutical Co., Ltd.'s pipeline depth and focus of pipeline therapeutics

Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
ankur [@] kenresearch.com
+91-9015378249
www.kenresearch.com

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 4

Kuhnil Pharmaceutical Co., Ltd. Snapshot 5

Kuhnil Pharmaceutical Co., Ltd. Overview 5

Key Information 5

Key Facts 5

Kuhnil Pharmaceutical Co., Ltd.-Research and Development Overview 6

Key Therapeutic Areas 6

Kuhnil Pharmaceutical Co., Ltd.-Pipeline Review 8

Pipeline Products by Stage of Development 8

Pipeline Products-Monotherapy 9

Pipeline Products-Partnered Products 10

Partnered Products/Combination Treatment Modalities 11

Kuhnil Pharmaceutical Co., Ltd.-Pipeline Products Glance 12

Kuhnil Pharmaceutical Co., Ltd.-Late Stage Pipeline Products 12

Phase III Products/Combination Treatment Modalities 12

Kuhnil Pharmaceutical Co., Ltd.-Clinical Stage Pipeline Products 13

Phase II Products/Combination Treatment Modalities 13

Phase I Products/Combination Treatment Modalities 14

Kuhnil Pharmaceutical Co., Ltd.-Early Stage Pipeline Products 15

Preclinical Products/Combination Treatment Modalities 15

Discovery Products/Combination Treatment Modalities 16

Kuhnil Pharmaceutical Co., Ltd.-Drug Profiles 17

KI-0501 17

Product Description 17

Mechanism of Action 17

R&D Progress 17

nimotuzumab 18

Product Description 18

Mechanism of Action 18

R&D Progress 18

KI-0503 22

Product Description 22

Mechanism of Action 22

R&D Progress 22

KI-1102 23

Product Description 23

Mechanism of Action 23

R&D Progress 23

KI-1104 24

Product Description 24

Mechanism of Action 24

R&D Progress 24

KI-0801 25

Product Description 25

Mechanism of Action 25

R&D Progress 25

KI-1002 26

Product Description 26

Mechanism of Action 26

R&D Progress 26

KI-1003 27

Product Description 27

Mechanism of Action 27

R&D Progress 27

KI-1007 28

Product Description 28

Mechanism of Action 28

R&D Progress 28

KI-1101 29

Product Description 29

Mechanism of Action 29

R&D Progress 29

KI-1103 30

Product Description 30

Mechanism of Action 30

R&D Progress 30

KI-1105 31

Product Description 31

Mechanism of Action 31

R&D Progress 31

Kuhnil Pharmaceutical Co., Ltd.-Pipeline Analysis 32

Kuhnil Pharmaceutical Co., Ltd.-Pipeline Products by Target 32

Kuhnil Pharmaceutical Co., Ltd.-Pipeline Products by Route of Administration 33

Kuhnil Pharmaceutical Co., Ltd.-Pipeline Products by Molecule Type 34

Kuhnil Pharmaceutical Co., Ltd.-Pipeline Products by Mechanism of Action 35

Kuhnil Pharmaceutical Co., Ltd.-Recent Pipeline Updates 36

Kuhnil Pharmaceutical Co., Ltd.-Locations And Subsidiaries 37

Head Office 37

Other Locations & Subsidiaries 37

Appendix 38

Methodology 38

Coverage 38

Secondary Research 38

Primary Research 38

Expert Panel Validation 38

Contact Us 38

Disclaimer 39

List of Figures

Kuhnil Pharmaceutical Co., Ltd.-Pipeline by Top 10 Indication, 2016 7

Kuhnil Pharmaceutical Co., Ltd.-Pipeline by Stage of Development, 2016 8

Kuhnil Pharmaceutical Co., Ltd.-Monotherapy Products in Pipeline, 2016 9

Kuhnil Pharmaceutical Co., Ltd.-Partnered Products in Pipeline, 2016 10

Kuhnil Pharmaceutical Co., Ltd.-Pipeline by Target, 2016 32

Kuhnil Pharmaceutical Co., Ltd.-Pipeline by Route of Administration, 2016 33

Kuhnil Pharmaceutical Co., Ltd.-Pipeline by Molecule Type, 2016 34

Kuhnil Pharmaceutical Co., Ltd.-Pipeline Products by Mechanism of Action, 2016 35

List of Tables

Kuhnil Pharmaceutical Co., Ltd., Key Information 5

Kuhnil Pharmaceutical Co., Ltd., Key Facts 5

Kuhnil Pharmaceutical Co., Ltd.-Pipeline by Indication, 2016 7

Kuhnil Pharmaceutical Co., Ltd.-Pipeline by Stage of Development, 2016 8

Kuhnil Pharmaceutical Co., Ltd.-Monotherapy Products in Pipeline, 2016 9

Kuhnil Pharmaceutical Co., Ltd.-Partnered Products in Pipeline, 2016 10

Kuhnil Pharmaceutical Co., Ltd.-Partnered Products/ Combination Treatment Modalities, 2016 11

Kuhnil Pharmaceutical Co., Ltd.-Phase III, 2016 12

Kuhnil Pharmaceutical Co., Ltd.-Phase II, 2016 13

Kuhnil Pharmaceutical Co., Ltd.-Phase I, 2016 14

Kuhnil Pharmaceutical Co., Ltd.-Preclinical, 2016 15

Kuhnil Pharmaceutical Co., Ltd.-Discovery, 2016 16

Kuhnil Pharmaceutical Co., Ltd.-Pipeline by Target, 2016 32

Kuhnil Pharmaceutical Co., Ltd.-Pipeline by Route of Administration, 2016 33

Kuhnil Pharmaceutical Co., Ltd.-Pipeline by Molecule Type, 2016 34

Kuhnil Pharmaceutical Co., Ltd.-Pipeline Products by Mechanism of Action, 2016 35

Kuhnil Pharmaceutical Co., Ltd.-Recent Pipeline Updates, 2016 36

Kuhnil Pharmaceutical Co., Ltd., Other Locations 37

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Current R&D Portfolio of Kuhnil Pharmaceutical Co., Ltd.; Kuhnil Pharmaceutical Co., Ltd.-Key Therapeutics; Kuhnil Pharmaceutical Co., Ltd.-Pipeline Overview and Promising Molecules; Kuhnil Pharmaceutical Co., Ltd.-News; Kuhnil Pharmaceutical Co., Ltd.-Latest Updates; Kuhnil Pharmaceutical Co., Ltd.-Pipeline; Kuhnil Pharmaceutical Co., Ltd.-Discontinued/Dormant Projects


Related Products in vertical
Other reports by publisher
Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

query [@] kenresearch.com